These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16316350)

  • 21. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease.
    Ritthaler U; Deng Y; Zhang Y; Greten J; Abel M; Sido B; Allenberg J; Otto G; Roth H; Bierhaus A
    Am J Pathol; 1995 Mar; 146(3):688-94. PubMed ID: 7887450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.
    Chello M; Spadaccio C; Lusini M; Covino E; Blarzino C; De Marco F; Di Domenico F; Coccia R
    Diabetes Metab Res Rev; 2009 Jul; 25(5):420-6. PubMed ID: 19405075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques.
    Inoue K; Kawahara K; Biswas KK; Ando K; Mitsudo K; Nobuyoshi M; Maruyama I
    Cardiovasc Pathol; 2007; 16(3):136-43. PubMed ID: 17502242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
    Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
    Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of peroxisome proliferators activated receptor gamma in mediating proliferation of rat vascular smooth muscle cells induced by advanced glycation end products].
    Yuan XC; Liu NF; Yan JC; Zhang X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):940-4. PubMed ID: 16266488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Horm Metab Res; 2013 May; 45(5):387-90. PubMed ID: 23225247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced glycation endproducts induce a proliferative response in vascular smooth muscle cells via altered calcium signaling.
    David KC; Scott RH; Nixon GF
    Biochem Pharmacol; 2008 Oct; 76(9):1110-20. PubMed ID: 18775682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts.
    Osawa M; Yamamoto Y; Munesue S; Murakami N; Sakurai S; Watanabe T; Yonekura H; Uchigata Y; Iwamoto Y; Yamamoto H
    Biochim Biophys Acta; 2007 Oct; 1770(10):1468-74. PubMed ID: 17714874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Receptors for advanced glycation end products and their physiological and clinical significance].
    Pietkiewicz J; Seweryn E; Bartyś A; Gamian A
    Postepy Hig Med Dosw (Online); 2008 Oct; 62():511-23. PubMed ID: 18936727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation end-products downregulating intervertebral disc cell production of proteoglycans in vitro.
    Yokosuka K; Park JS; Jimbo K; Yamada K; Sato K; Tsuru M; Takeuchi M; Yamagishi S; Nagata K
    J Neurosurg Spine; 2006 Oct; 5(4):324-9. PubMed ID: 17048769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose.
    Toma L; Stancu CS; Botez GM; Sima AV; Simionescu M
    Biochem Biophys Res Commun; 2009 Dec; 390(3):877-82. PubMed ID: 19850013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells.
    Di BB; Li HW; Li WP; Shen XH; Sun ZJ; Wu X
    Mol Med Rep; 2015 Apr; 11(4):2601-7. PubMed ID: 25523934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y; Lin S; Zhou J
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced glycation end products promote proliferation and suppress autophagy via reduction of Cathepsin D in rat vascular smooth muscle cells.
    Ma M; Guo X; Chang Y; Li C; Meng X; Li S; Du ZX; Wang HQ; Sun Y
    Mol Cell Biochem; 2015 May; 403(1-2):73-83. PubMed ID: 25673507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction.
    Fukami K; Ueda S; Yamagishi S; Kato S; Inagaki Y; Takeuchi M; Motomiya Y; Bucala R; Iida S; Tamaki K; Imaizumi T; Cooper ME; Okuda S
    Kidney Int; 2004 Dec; 66(6):2137-47. PubMed ID: 15569303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.
    Brett J; Schmidt AM; Yan SD; Zou YS; Weidman E; Pinsky D; Nowygrod R; Neeper M; Przysiecki C; Shaw A
    Am J Pathol; 1993 Dec; 143(6):1699-712. PubMed ID: 8256857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes.
    Cuccurullo C; Iezzi A; Fazia ML; De Cesare D; Di Francesco A; Muraro R; Bei R; Ucchino S; Spigonardo F; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A; Cipollone F
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2716-23. PubMed ID: 17038636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
    Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
    Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
    Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
    J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.